Feb DecisionSo everyone here is in on a hope and prayer, forgetting the fact that if the FDA does not heed Adcomm advice, it makes Adcomm irrelevant. Without a serious rework of the plan and indication, does anyone really think this MCNA will get the nod? With tax loss selling and no Nr for a rework this will go to .20 again, before any movement upward. I could be wrong, but 7 years of BNC & TST, has given me plenty of reasons for doubt.